FDA Clears Expanded Indications for Swift Microwave Wart Device
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.
New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.
The move brings Xeomin and Radiesse to China as part of the company’s broader international expansion.